Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study

BMJ

Volumn 313, Issue 7054, 1996, Pages 387-391

  Arason, Vilhjalmur A ^a   Sigurdsson, Johann A ^a   Kristinsson, Karl G ^b   Stefansdottir, Gudrun ^c   Molstad, Sigvard ^d   Gudmundsson, Sigurdur ^e  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c Microbiology Laboratory   (Iceland)

^d Hoor Health Centre   (Sweden)

^e Department of Internal Medicine ^*  (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CARRIER; DRUG USE; GEOGRAPHIC DISTRIBUTION; HUMAN; ICELAND; INFANT; MULTIVARIATE ANALYSIS; NASOPHARYNX; PENICILLIN RESISTANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

AGE FACTORS; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; ICELAND; INFANT; INFANT, NEWBORN; MALE; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL DISEASES; NASOPHARYNX; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PREVALENCE; RESIDENCE CHARACTERISTICS; STREPTOCOCCUS PNEUMONIAE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0029759520     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.313.7054.387     Document Type: Article

References (26)

1. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77–83.
2. Geslin P, Buu-Hoi A, Fremaux A, Acar JF. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clin Infect Dis 1992; 15: 95–98.
3. Linares J, Pallares R, Alonso T, Perez JL, Ayats J, Gudiol F et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992; 15: 99–105.
4. Marton A, Gulyas M, Munoz R, Tomasz A. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis 1991; 163: 542–548.
5. Hofmann J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliott JA et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995; 333: 481–486.
6. Kristinsson KG, Hjamarsdottir MA, Steingrimsson O. Increasing penicillin resistance in pneumococci in Iceland. Lancet 1992; 339: 1606–7.
7. Kristinsson KG. Epidemiology of penicillin resistant pneumococci in Iceland. Microbial Drug Resistance 1995; 1: 121–125.
8. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993; 168: 158–163.
9. McGowan Jr JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 5: 1033–9.
10. Seppala H, Nissinen A, Jarvinen H, Huovinen S, Henriksson T, Herva E et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 326: 292–297.
11. Molstad S, Arvidsson E, Eliasson I, Hovelius B, Kamme C, Schalen C. Production of beta-lactamase by respiratory tract bacteria in children: relationship to antibiotic use. Scand J Prim Health Care 1992; 10: 16–20.
12. Nordiska Lakemedelsnamnden. Nordic statistics on medicines 1990-92. Uppsala: Nordic Council on Medicines, 1993. (NLN publication No 34.)
13. World Health Organisation. Anatomical therapeutical chemical (ACT) classification index including defined daily doses (DDDs) for plain substances. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1992.
14. Ruoff KL. Streptococcus.In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology Press, 1995: 299–307.
15. Woods GL, Washington JA. Antimicrobial susceptibility tests: dilution and disk diffusion methods.In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology Press, 1995: 1327–41.
16. Swenson JM, Hill BC, Thornsberry C. Screening pneumococci for penicillin resistance. J Clin Microbiol 1986; 24: 749–752.
17. Kronvall G. A rapid slide-agglutination method for typing pneumococci by means of a specific antibody adsorbed to protein-A-containing staphylococci. J Med Microbiol 1973; 6: 187–190.
18. Hosmer Jr DW, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons, 1989: 83.
19. Miettinen OS. Stratification by multivariate confounder score. Am J Epidemiol 1976; 104: 425–435.
20. Neu HC. The crisis in antibiotic resistance. Science 1992; 257: 1064–73.
21. Jacoby GA, Archer GL. New mechanism of bacterial resistance to antimicrobial agents. N Engl J Med 1991; 324: 601–612.
22. Kunin CM. Problems in antibiotic usage.In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1990: 427–434.
23. Austrian R. Some aspects of the pneumococcal carrier state. J Antimicrob Chemother 1986; 18 (suppl A): 35–45.
24. Gray BM, Converse III GM, Dillon Jr HC. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980; 142: 923–933.
25. Bro F, Mabeck CE. Use of antibiotics in general practice in Denmark. Scand J Prim Health Care 1986; 4: 101–104.
26. Reichler MR, Allphin AA, Breiman RF, Schreiber JR, Arnold JE, McDougal LR et al. The spread of multiply resistant Streptococcus pneumoniae at day care center in Ohio. J Infect Dis 1992; 166: 1346–53.